Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 1 | 2018 | 14 | 0.600 |
Why?
|
| Uveitis | 1 | 2018 | 30 | 0.570 |
Why?
|
| B7-1 Antigen | 6 | 2011 | 73 | 0.520 |
Why?
|
| Vaccinia | 1 | 2012 | 31 | 0.410 |
Why?
|
| Vaccinia virus | 1 | 2012 | 71 | 0.400 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 86 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 619 | 0.390 |
Why?
|
| Antigens, Viral | 1 | 2012 | 131 | 0.390 |
Why?
|
| Kidney Transplantation | 2 | 2019 | 267 | 0.380 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 848 | 0.350 |
Why?
|
| Peptides | 4 | 2011 | 545 | 0.340 |
Why?
|
| Heart Transplantation | 5 | 2013 | 159 | 0.340 |
Why?
|
| Escherichia coli Infections | 3 | 2014 | 87 | 0.310 |
Why?
|
| Goiter | 1 | 2008 | 9 | 0.300 |
Why?
|
| Thyroid Gland | 1 | 2008 | 78 | 0.280 |
Why?
|
| Racemases and Epimerases | 1 | 2006 | 24 | 0.270 |
Why?
|
| Prostate | 1 | 2006 | 54 | 0.260 |
Why?
|
| Graft Rejection | 4 | 2013 | 259 | 0.260 |
Why?
|
| Virus Diseases | 2 | 2021 | 111 | 0.260 |
Why?
|
| Carcinoma | 1 | 2006 | 117 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 197 | 0.240 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2023 | 8 | 0.220 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2023 | 14 | 0.220 |
Why?
|
| Enterohemorrhagic Escherichia coli | 2 | 2014 | 13 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2014 | 1996 | 0.220 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 320 | 0.210 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 667 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 193 | 0.210 |
Why?
|
| Pathologists | 1 | 2022 | 11 | 0.210 |
Why?
|
| CD28 Antigens | 3 | 2013 | 59 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 221 | 0.190 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2021 | 8 | 0.190 |
Why?
|
| Antigens, CD | 3 | 2011 | 343 | 0.190 |
Why?
|
| Pneumococcal Infections | 1 | 2021 | 35 | 0.190 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2021 | 13 | 0.190 |
Why?
|
| Streptococcus pneumoniae | 1 | 2021 | 59 | 0.190 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 33 | 0.180 |
Why?
|
| Virulence | 3 | 2021 | 189 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 148 | 0.180 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 739 | 0.180 |
Why?
|
| Coinfection | 1 | 2021 | 45 | 0.180 |
Why?
|
| Mice | 15 | 2021 | 10307 | 0.180 |
Why?
|
| Thrombospondin 1 | 1 | 2000 | 6 | 0.170 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 95 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 3206 | 0.170 |
Why?
|
| Histidine | 1 | 2000 | 31 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2014 | 647 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 238 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2013 | 2890 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2021 | 192 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 75 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 114 | 0.150 |
Why?
|
| Skin | 1 | 2021 | 356 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 707 | 0.150 |
Why?
|
| Syndrome | 1 | 2018 | 172 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 176 | 0.140 |
Why?
|
| Autoantibodies | 2 | 2023 | 175 | 0.140 |
Why?
|
| Animals | 16 | 2021 | 19719 | 0.140 |
Why?
|
| T-Lymphocytes | 3 | 2010 | 968 | 0.130 |
Why?
|
| Shiga Toxin | 2 | 2014 | 4 | 0.130 |
Why?
|
| Th2 Cells | 2 | 2013 | 98 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2012 | 145 | 0.120 |
Why?
|
| Aging | 1 | 2021 | 731 | 0.120 |
Why?
|
| Obesity | 1 | 2022 | 1187 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2014 | 280 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 35 | 0.110 |
Why?
|
| Humans | 16 | 2023 | 59816 | 0.110 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2013 | 7 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 56 | 0.110 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2013 | 22 | 0.110 |
Why?
|
| Bleaching Agents | 1 | 2013 | 6 | 0.110 |
Why?
|
| Sodium Hypochlorite | 1 | 2013 | 12 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2011 | 174 | 0.110 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2012 | 8 | 0.100 |
Why?
|
| Citrobacter rodentium | 1 | 2012 | 5 | 0.100 |
Why?
|
| Kidney | 2 | 2013 | 394 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 90 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2012 | 123 | 0.100 |
Why?
|
| Actins | 1 | 2014 | 257 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 62 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2014 | 221 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 2 | 2011 | 176 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2014 | 192 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2013 | 309 | 0.090 |
Why?
|
| Growth Inhibitors | 1 | 2011 | 27 | 0.090 |
Why?
|
| Self Tolerance | 1 | 2011 | 18 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 131 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 256 | 0.090 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 65 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 2011 | 30 | 0.090 |
Why?
|
| Renal Dialysis | 2 | 2013 | 185 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 51 | 0.090 |
Why?
|
| Isoantigens | 1 | 2010 | 71 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 171 | 0.080 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 1 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 880 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 32 | 0.080 |
Why?
|
| Male | 7 | 2023 | 27769 | 0.080 |
Why?
|
| Cytokines | 1 | 2012 | 909 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 439 | 0.080 |
Why?
|
| Parathyroid Glands | 1 | 2008 | 8 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2008 | 32 | 0.070 |
Why?
|
| Female | 8 | 2019 | 31098 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 843 | 0.070 |
Why?
|
| Amyloid | 1 | 2008 | 63 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2008 | 189 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2008 | 191 | 0.070 |
Why?
|
| Nephrosis, Lipoid | 1 | 2006 | 6 | 0.070 |
Why?
|
| B7-H1 Antigen | 3 | 2011 | 53 | 0.070 |
Why?
|
| Immunization | 1 | 2006 | 127 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 128 | 0.060 |
Why?
|
| Adult | 3 | 2019 | 15882 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 603 | 0.060 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2011 | 56 | 0.060 |
Why?
|
| Ligands | 3 | 2011 | 421 | 0.060 |
Why?
|
| Transplantation, Homologous | 3 | 2011 | 234 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2100 | 0.060 |
Why?
|
| Phospholipases | 1 | 2023 | 9 | 0.060 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2023 | 2 | 0.060 |
Why?
|
| Toluene | 1 | 2023 | 7 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 71 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2006 | 328 | 0.050 |
Why?
|
| Polyesters | 1 | 2023 | 47 | 0.050 |
Why?
|
| Government Agencies | 1 | 2022 | 9 | 0.050 |
Why?
|
| Antibodies, Blocking | 2 | 2013 | 40 | 0.050 |
Why?
|
| Protein Binding | 2 | 2011 | 1559 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 16401 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 37 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 32 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2021 | 39 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1538 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 157 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 70 | 0.050 |
Why?
|
| Chemokines | 1 | 2021 | 94 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 638 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2000 | 16 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2079 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 48 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2021 | 117 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2000 | 32 | 0.040 |
Why?
|
| Disulfides | 1 | 2000 | 62 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 334 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 86 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 44 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 194 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 48 | 0.040 |
Why?
|
| Graft Survival | 2 | 2011 | 279 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 110 | 0.040 |
Why?
|
| Heparin | 1 | 2000 | 111 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 303 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2000 | 101 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 323 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1225 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 596 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 696 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 870 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1519 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 857 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 1579 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 557 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5205 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 182 | 0.030 |
Why?
|
| Jagged-2 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Young Adult | 1 | 2023 | 4365 | 0.030 |
Why?
|
| Astrocytes | 1 | 2014 | 116 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 183 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 64 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 148 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 104 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2014 | 197 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 107 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2014 | 528 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 304 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2012 | 59 | 0.020 |
Why?
|
| Suicide, Attempted | 1 | 2013 | 103 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 548 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 264 | 0.020 |
Why?
|
| Inbreeding | 1 | 2011 | 5 | 0.020 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2011 | 22 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 209 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 104 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 40 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2011 | 151 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 218 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2010 | 70 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 82 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 84 | 0.020 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 506 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2009 | 55 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 511 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1311 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2009 | 36 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 48 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 164 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 13461 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 222 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 273 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 158 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 53 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 118 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 115 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1975 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 161 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 98 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2009 | 175 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 187 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 31 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2008 | 133 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 179 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 741 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7570 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 461 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 710 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 838 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 169 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5939 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 5149 | 0.010 |
Why?
|